NASDAQ:NRC National Research (NRC) Stock Price, News & Analysis $21.05 -0.52 (-2.41%) As of 10:30 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About National Research Stock (NASDAQ:NRC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get National Research alerts:Sign Up Key Stats Today's Range$21.02▼$21.7750-Day Range$18.30▼$22.3452-Week Range$11.01▼$23.68Volume6,733 shsAverage Volume113,194 shsMarket Capitalization$478.80 millionP/E Ratio84.20Dividend Yield3.04%Price Target$26.00Consensus RatingModerate Buy Company Overview National Research Corporation, doing business as NRC Health, provides research, analytics and technology solutions to the health care industry. The company helps hospitals, health systems and other care organizations understand patient and consumer perceptions, improve the care experience and strengthen relationships with the communities they serve. Its offerings include patient and employee experience measurement, market and consumer insights, reputation management, customer relationship tools and analytics designed to support service improvement and strategic decision-making. NRC Health combines survey-based research, benchmarking and software-enabled reporting to help organizations identify trends and evaluate performance across the patient journey. Founded in 1981 and headquartered in Lincoln, Nebraska, National Research has served health care organizations in the United States and Canada. The company markets its solutions under the NRC Health name and focuses primarily on hospitals, health systems, physician practices and other organizations involved in delivering health care.AI Generated. May Contain Errors. Read More National Research Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks47th Percentile Overall ScoreNRC MarketRank™: National Research scored higher than 47% of companies evaluated by MarketBeat, and ranked 553rd out of 901 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingNational Research has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and no sell ratings.Upside PotentialNational Research has a consensus price target of $26.00, representing about 20.5% upside from its current price of $21.57.Amount of Analyst CoverageNational Research has only been the subject of 2 research reports in the past 90 days.Read more about National Research's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of National Research is 86.28, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.00.Price to Earnings Ratio vs. SectorThe P/E ratio of National Research is 86.28, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.08.Price to Book Value per Share RatioNational Research has a P/B Ratio of 34.79. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about National Research's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted3.08% of the float of National Research has been sold short.Short Interest Ratio / Days to CoverNational Research has a short interest ratio ("days to cover") of 5.54.Change versus previous monthShort interest in National Research has recently increased by 14.86%, indicating that investor sentiment is decreasing significantly. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldNational Research pays a meaningful dividend of 3.01%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthNational Research does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of National Research is 256.00%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about National Research's dividend. News and Social Media2.3 / 5News SentimentN/A News SentimentNational Research has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for National Research this week, compared to 1 article on an average week. Company Ownership0.9 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, National Research insiders have not sold or bought any company stock.Percentage Held by Insiders9.20% of the stock of National Research is held by insiders.Percentage Held by Institutions47.26% of the stock of National Research is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about National Research's insider trading history. Receive NRC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NRC Stock News HeadlinesMercy Earns National Honor for Excellence in Patient ExperienceSeptember 1, 2026 | prnewswire.comRecord Backlog Powers NRC Health’s (NRC) Upward PotentialAugust 10, 2026 | insidermonkey.comElon’s AI Phone is comingRumors are swirling that Elon Musk is developing a new mobile device that could rival the iPhone. It's said to be thinner, longer-lasting on battery, and cheaper to produce, with the ability to work worldwide without relying on cell towers. Former Bloomberg reporter and SAC Capital trader Josh Baylin says the evidence is mounting. He notes the FCC recently gave Musk a green light connected to his mobile plans, adding fuel to speculation. Baylin previously called the smartphone boom in 2004 and predicted Apple would sell a billion phones when others expected a fraction of that.September 24 at 1:00 AM | Stansberry Research (Ad)National Research: Q2 Earnings SnapshotJuly 30, 2026 | finance.yahoo.comNRC Health (NRC) Q2 2026 Earnings Call TranscriptJuly 29, 2026 | seekingalpha.comNRC Health Announces Second Quarter 2026 ResultsJuly 28, 2026 | businesswire.comMMF and NRC Agree to the Transfer of Property at 435-445 Ellice Avenue, WinnipegJuly 10, 2026 | ca.finance.yahoo.comNational Research Shareholders Approve Governance Reforms and DirectorsJune 29, 2026 | tipranks.comSee More Headlines NRC Stock Analysis - Frequently Asked Questions How have NRC shares performed this year? National Research's stock was trading at $18.77 at the beginning of 2026. Since then, NRC stock has increased by 14.9% and is now trading at $21.57. How were National Research's earnings last quarter? National Research Corporation (NASDAQ:NRC) issued its quarterly earnings results on Tuesday, July, 28th. The company reported $0.31 EPS for the quarter, topping the consensus estimate of ($0.15) by $0.46. The business had revenue of $35.39 million for the quarter, compared to analyst estimates of $34.90 million. National Research had a net margin of 4.18% and a trailing twelve-month return on equity of 164.26%. Read the conference call transcript. Does National Research have any subsidiaries? National Research subsidiaries include PatientWisdom Inc., The Governance Institute, and National Research Corporation Canada. Who are National Research's major shareholders? National Research's top institutional investors include QV Investors Inc. (1.64%), Squarepoint Ops LLC (0.16%), Empirical Finance LLC (0.09%) and California State Teachers Retirement System. Insiders that own company stock include Amandla Mk Trust, Patrick E Beans and Jordan Nicole Freeman. View institutional ownership trends. How do I buy shares of National Research? Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of National Research own? Based on aggregate information from My MarketBeat watchlists, some other companies that National Research investors own include Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Alphabet (GOOG), Netflix (NFLX), Advanced Micro Devices (AMD) and JPMorgan Chase & Co. (JPM). Company Calendar Record date for 7/10 Dividend6/26/2026Ex-Dividend for 7/10 Dividend6/26/2026Dividend Payable7/10/2026Last Earnings7/28/2026Today9/24/2026Record date for 10/9 Dividend9/25/2026Ex-Dividend for 10/9 Dividend9/25/2026Dividend Payable10/09/2026Next Earnings (Estimated)10/26/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 NRC's financial health is in the Green zone, according to TradeSmith. NRC has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Technology Sub-IndustryHealthcare Technology Current SymbolNASDAQ:NRC CIK70487 Webwww.nrchealth.com Phone(402) 475-2525Fax402-475-9061Employees357Year Founded1981Price Target and Rating Average Price Target for National Research$26.00 High Price Target$26.00 Low Price Target$26.00 Potential Upside/Downside+23.3%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)$0.25 Trailing P/E Ratio84.55 Forward P/E RatioN/A P/E GrowthN/ANet Income$11.60 million Net Margins4.18% Pretax Margin6.70% Return on Equity164.26% Return on Assets14.67% Debt Debt-to-Equity Ratio13.13 Current Ratio0.65 Quick Ratio0.65 Sales & Book Value Annual Sales$140.00 million Price / Sales3.42 Cash Flow$1.21 per share Price / Cash Flow17.39 Book Value$0.62 per share Price / Book34.00Miscellaneous Outstanding Shares22,746,000Free Float20,653,000Market Cap$479.49 million OptionableOptionable Beta0.35 Social Links 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (NASDAQ:NRC) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | SponsoredWhy I believe the AI market will split in Q4Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...The Oxford Club | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredCongress Passes Landmark Digital Asset Law Wall Street Is WatchingThe House passed the Digital Asset Market Clarity Act 294 to 134, creating the most comprehensive financial te...Awesomely | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Research Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share National Research With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
